Morse Asset Management Inc Purchases New Holdings in Thermo Fisher Scientific Inc (TMO)
Morse Asset Management Inc purchased a new stake in Thermo Fisher Scientific Inc (NYSE:TMO) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,094 shares of the medical research company’s stock, valued at approximately $207,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Proficio Capital Partners LLC lifted its stake in Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after buying an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC bought a new stake in shares of Thermo Fisher Scientific during the second quarter valued at about $108,000. Shine Investment Advisory Services Inc. bought a new stake in shares of Thermo Fisher Scientific during the second quarter valued at about $113,000. Ropes Wealth Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 15.8% during the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after purchasing an additional 97 shares in the last quarter. Finally, Atlantic Trust LLC bought a new stake in Thermo Fisher Scientific in the second quarter worth about $138,000. Hedge funds and other institutional investors own 85.32% of the company’s stock.
In other news, VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction on Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the sale, the vice president now owns 25,518 shares in the company, valued at $4,537,100.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director C Martin Harris sold 360 shares of the stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total value of $65,149.20. Following the sale, the director now owns 5,312 shares in the company, valued at approximately $961,312.64. The disclosure for this sale can be found here. Insiders have sold 60,420 shares of company stock worth $11,308,477 in the last 90 days. Company insiders own 0.49% of the company’s stock.
TMO has been the topic of several research reports. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a research report on Thursday, September 7th. Cowen Inc reissued a “buy” rating and issued a $200.00 price target on shares of Thermo Fisher Scientific in a research note on Friday, September 1st. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. BidaskClub cut Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Goldman Sachs Group, Inc. (The) assumed coverage on Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price target on the stock. One investment analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $205.71.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/morse-asset-management-inc-purchases-new-holdings-in-thermo-fisher-scientific-inc-tmo/1723797.html.
Thermo Fisher Scientific Inc (NYSE TMO) traded down $0.45 on Friday, hitting $192.30. The stock had a trading volume of 40,567 shares, compared to its average volume of 1,543,035. The company has a market capitalization of $77,291.86, a PE ratio of 21.18, a PEG ratio of 1.76 and a beta of 1.08. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $201.20.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the business posted $2.03 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 13.9% on a year-over-year basis. analysts anticipate that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.19%.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.